Tobam increased its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 56.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,743 shares of the company's stock after acquiring an additional 1,351 shares during the quarter. Tobam's holdings in Molina Healthcare were worth $1,233,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of MOH. Wellington Management Group LLP boosted its holdings in Molina Healthcare by 7.4% in the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after purchasing an additional 181,073 shares during the period. FMR LLC raised its position in shares of Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock worth $524,214,000 after buying an additional 427,276 shares in the last quarter. Geode Capital Management LLC grew its position in Molina Healthcare by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after buying an additional 34,992 shares in the last quarter. Invesco Ltd. grew its position in Molina Healthcare by 28.5% during the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock worth $386,229,000 after buying an additional 294,180 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Molina Healthcare by 15.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock worth $200,307,000 after acquiring an additional 91,229 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.
Insider Buying and Selling
In related news, CEO Joseph M. Zubretsky sold 87,500 shares of the business's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares in the company, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now owns 11,244 shares of the company's stock, valued at $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
MOH has been the subject of several recent analyst reports. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Wall Street Zen raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, April 11th. Mizuho lifted their price objective on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Guggenheim initiated coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Finally, Sanford C. Bernstein initiated coverage on Molina Healthcare in a research report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target on the stock. Nine equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, Molina Healthcare currently has an average rating of "Hold" and a consensus price target of $364.21.
View Our Latest Analysis on Molina Healthcare
Molina Healthcare Trading Up 1.7%
NYSE MOH traded up $4.91 during trading hours on Friday, hitting $298.39. 630,608 shares of the company were exchanged, compared to its average volume of 686,529. The stock has a market cap of $16.17 billion, a PE ratio of 14.61, a price-to-earnings-growth ratio of 1.06 and a beta of 0.57. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average price of $316.10 and a 200 day moving average price of $307.20. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The company had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same period last year, the business posted $5.73 EPS. Molina Healthcare's quarterly revenue was up 12.2% on a year-over-year basis. Analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.